article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics

XTalks

The top 15 diabetes drugs in 2023, according to 2022 sales data, reflect the current state of diabetes management and hint at the evolving needs and trends within this critical area of healthcare. Read on to learn more about the top 15 diabetes drugs in 2023, based on 2022 sales statistics. mL subcutaneous solution (2 mg/1.5

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This is the Newest Functional Beverage from the Co-Founders of Oatly and Fiji Water

XTalks

While the line was initially launched in 2018 under the name “The Swedish Sugar Buster,” the re-launch features new packaging and flavors that are more suitable for today’s functional beverage market. The drinks are available for sale on Good Idea’s website for a suggested retail price of $2.49, with retail locations to be announced.

article thumbnail

Health Canada’s proposed amendments to the Food and Drug Regulations and the Medical Devices Regulations

Pharma in Brief

Individual standards for certain biologic drugs ( e.g. , insulin) would be repealed in favor of relying on the standards set out in Schedule B to the Food and Drugs Act. Where no Schedule B standard exists, or where the available standard is unusable, the amendments would allow for the use of an alternative standard. On-site Evaluations.

article thumbnail

A USD 4.2 Billion Myovant/ Pfizer Deal; Audentes Therapeutics’ ASPIRO Trial Free to Proceed; First Generic of Drug for Severe Hypoglycemia Gets Approval; Teleflex Acquires Z-Medica

Delveinsight

billion – a deal that is split into upfront payments, and sales and regulatory milestone payments. Food and Drug Administration has given a green signal to the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia. .

Trials 52
article thumbnail

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

pharmaphorum

We’d like to get to a point where our treatment and prevention offering can be packaged together for the NHS – because both go hand in hand, alongside digital tools”. We’d like to get to a point where our treatment and prevention offering can be packaged together – because both go hand in hand, alongside digital tools.”.

article thumbnail

Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance

The Pharma Data

The company confirmed the tirzepatide SURPASS program has met global regulatory submission requirements for evaluating cardiovascular risk and its intention to submit the registration package to regulatory authorities by the end of 2021. million of revenue associated with the sale of its rights to Cialis ® in China. Excluding $148.9